青年缺血性卒中后他汀使用与长期结局的关联
研究基于赫尔辛基青年卒中登记(1994–2007)中935例15–49岁首发缺血性卒中30天存活者,随访至2012年。46.8%的患者在随访期间使用他汀;调整混杂因素后,他汀使用与全因死亡(HR 0.38,95%CI 0.25–0.58)和复发性卒中(HR 0.29,95%CI 0.19–0.44)风险降低独立相关,倾向评分匹配后结果不变。
要点
- 青年缺血性卒中患者他汀使用率不足半数(46.8%)。
核心结论
- 青年缺血性卒中患者他汀使用率低,且受年龄和危险因素特征影响。
- 他汀使用与全因死亡和复发性卒中风险降低独立相关。
研究设计与样本
- 基于赫尔辛基青年卒中登记(1994–2007)的队列研究,纳入935例15–49岁首发缺血性卒中30天存活者,随访至2012年。
- 通过调整Cox回归和倾向评分匹配分析他汀使用(至少2次购买)与结局的关联。
主要发现
- 935例患者中46.8%在随访期间使用过他汀。
- 较高年龄、血脂异常、大量饮酒和高血压与购买他汀显著相关。
- 调整血脂异常、卒中亚型等混杂因素后,他汀使用者全因死亡风险HR 0.38(95%CI 0.25–0.58),复发性卒中风险HR 0.29(95%CI 0.19–0.44)。
- 倾向评分匹配比较后上述结果保持不变。
临床怎么用
- 应关注青年缺血性卒中患者他汀使用不足的问题。
- 对青年缺血性卒中存活者,尤其合并血脂异常、高血压等危险因素者,可考虑他汀二级预防以降低死亡和复发风险。
局限性
- 研究为观察性设计,不能证明因果关系。
- 他汀使用定义为至少2次购买,可能受依从性影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background and Purpose- Knowledge of the use of secondary preventive medication in young adults is limited. We studied the use of statins and its association with subsequent vascular events in young adults with ischemic stroke-a patient group with a known low burden of atherosclerosis. Methods- The study population included 935 first-ever 30-day ischemic stroke survivors aged 15 to 49 years from the Helsinki Young Stroke Registry, 1994 to 2007. Follow-up data until 2012 were obtained from the Social Insurance Institution of Finland (Drug Prescription Register), the Finnish Care Register, and Statistics Finland. The association of the use of statins (defined as at least 2 purchases) with all-cause mortality, recurrent stroke, and other recurrent vascular events was assessed through adjusted Cox regression analyses. We further compared propensity score-matched statin users with nonusers. Results- Of our 935 patients, 46.8% used statins at some point during follow-up. Higher age, dyslipidemia, heavy alcohol use, and hypertension were significantly associated with purchasing statins. Statin users exhibited lower risk of all-cause mortality (hazard ratio, 0.38 [95% CI, 0.25-0.58]) and recurrent stroke (hazard ratio, 0.29 [95% CI, 0.19-0.44]) than nonusers, after adjustment for dyslipidemia, stroke subtype, and other confounders. These results remained unchanged after propensity score-matched comparison. Conclusions- Less than half of young ischemic stroke patients used statins; use was affected by age and risk factor profile. Statin use was independently associated with lower risk of all-cause mortality and recurrent stroke.
引用
- van Dongen MME, Aarnio K, Martinez-Majander N, et al. Use of Statins After Ischemic Stroke in Young Adults and Its Association With Long-Term Outcome. Stroke. 2019. PMID: 31699020. doi:10.1161/STROKEAHA.119.026992
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。